Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - GROSS PROFIT
Gross Profit IBRX - ImmunityBio, Inc.
622 K
LAST VALUE
-18.39%
2 YEAR CAGR
-27.74%
5 YEAR CAGR
6.01%
10 YEAR CAGR